SIRBAL
associated with 1 other trademarks
Pharmaceuticals for the treatment of cancer, leukemia, melanoma, autoimmune disease, psoriasis, chrone, ulcerative colitis, arthritis and diabetes

Words that describe this trademark:

ulcerative colitis arthritis  cancer leukemia  disease psoriasis  treatment cancer  autoimmune disease  psoriasis  chrone  pharmaceuticals  leukemia  melanoma 

Serial Number:

85591829

Mark:

SIRBAL

Status:

Abandoned-No Statement of Use filed

Status Date:

06-27-2016

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Pharmaceuticals for the treatment of cancer, leukemia, melanoma, autoimmune disease, psoriasis, chrone, ulcerative colitis, arthritis and diabetes

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

03-26-2013

Mark Drawing Status:

Standart Character Mark

Abandon Date:

06-27-2016

Business Name:

N/A

Correspondent Name:

Recent Trademark filings by this company